Medicus Pharma Ltd. Common Stock (MDCX) is a publicly traded Healthcare sector company. As of October 23, 2026, MDCX trades at $2.62 with a market cap of $3.76M and a P/E ratio of -0.06. MDCX moved +0.00% today. Year to date, MDCX is -96.88%; over the trailing twelve months it is -97.94%. Its 52-week range spans $2.50 to $447.00. Analyst consensus is strong buy with an average price target of $8.33. Rallies surfaces MDCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MDCX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.62 |
| Market Cap | $3.76M |
| P/E Ratio | -0.06 |
| EPS | $-2.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $447.00 |
| 52-Week Low | $2.50 |
| Volume | 80.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $-261.25K |
| Net Income | $-44.89M |
| Gross Margin | 0.00% |
3 analysts cover MDCX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.33.